Skip to main content
. 2022 Dec 14;2022:1090313. doi: 10.1155/2022/1090313

Figure 1.

Figure 1

Flow chart shows the screening procedure for unresectable HCC patients treated with DEB-TACE or DEB-lipiodol TACE.